Photocoagulation and diabetic retinopathy
Related Articles
- Proliferative diabetic retinopathy: treatment with xenon-arc photocoagulation. // British Medical Journal;3/19/1977, Vol. 1 Issue 6063, p739
Examines the effect of xenon-arc photocoagulation in patients with varying degrees of proliferative retinopathy. Difference in visual acuities of the treated and untreated eyes; Cause of blindness in untreated eyes; Findings of the photographic and clinical assessment of disc new vessels.
- Diabetic retinopathy. Kohner, Eva M. // BMJ: British Medical Journal (International Edition);11/6/93, Vol. 307 Issue 6913, p1195
Focuses on the treatment of diabetic retinopathy. Complications of the disease; Effectivity of photocoagulation; Significance of screening for retinopathy.
- Scotomata from panretinal photocoagulation are not perceived as a result of perceptual filling-in generated by plasticity in the visual cortex. Dosso, Andre A.; Ustun-Yenice, Ferah; Safran, Avinoam B.; Dosso, A A; Ustun-Yenice, F; Safran, A B // Diabetes Care;Dec2000, Vol. 23 Issue 12, p1855
Focuses on a study which assessed the visual field defects in diabetic retinopathy patients who received panretinal photocoagulation. Methodology and results; Information on scotomas; Implication of the results.
- Light panretinal photocoagulation beneficial in PDR. Guttman, Cheryl; Bandello, Francesco M. // Ophthalmology Times;05/15/2000, Vol. 25 Issue 10, p40
Focuses on the efficacy of light panretinal photocoagulation (LPRP) in treating proliferative diabetic retinopathy. Effectiveness of LPRP compared to classic panretinal photocoagulation; Complications of LPRP treatment.
- Diabetic retinopathy: A growing concern in an aging population. Paulus, Yannis M.; Gariano, Ray F. // Geriatrics;Feb2009, Vol. 64 Issue 2, p16
The article focuses on diabetic retinopathy (DR), one of the complications of diabetes and a leading cause of irreversible blindness. Management of DR is offered which includes light laser treatment, the panretinal photocoagulation (PRP) laser treatment and the injection of anti-vascular...
- Advanced Glycation End Products (AGEs), Oxidative Stress and Diabetic Retinopathy. Yamagishi, Sho-ichi; Matsui, Takanori // Current Pharmaceutical Biotechnology;Mar2011, Vol. 12 Issue 3, p362
No abstract available.
- The Role of Oxidative Stress after Retinal Laser Photocoagulation in Nonproliferative Diabetic Retinopathy. Galetović, Davor; Bojić, Lovro; Bućan, Kajo; Karlica, Dobrila; Lešin, Mladen; Znaor, Ljubo // Collegium Antropologicum;Sep2011, Vol. 35 Issue 3, p835
Diabetic retinopathy (DR) represents the most common chronic complication of diabetes, and it is the leading cause of new cases of blindness in patients between 20-74 years old in developed countries. Laser photocoagulation (LF) represents an efficacious approach to the treatment of DR....
- Therapeutic implications of curcumin in the prevention of diabetic retinopathy via modulation of anti-oxidant activity and genetic pathways. Aldebasi, Yousef H.; Aly, Salah M.; Rahmani, Arshad H. // International Journal of Physiology, Pathophysiology & Pharmacol;2013, Vol. 5 Issue 4, p194
Diabetic Retinopathy (DR) is one of the most common complications of diabetes mellitus that affects the blood vessels of the retina, leading to blindness. The current approach of treatment based on anti-inflammatory, anti-angiogenesis drugs and laser photocoagulation are effective but also shows...
- Plasma E-selectin levels can play a role in the development of diabetic retinopathy. Kasza, Márta; Meleg, J.; Vardai, J.; Nagy, B.; Szalai, E.; Damjanovich, J.; Csutak, A.; Ujhelyi, B.; Nagy, V. // Graefe's Archive of Clinical & Experimental Ophthalmology;Jan2017, Vol. 255 Issue 1, p25
Purpose: Diabetic retinopathy is one of the leading causes of blindness. There are several risk factors, such as the duration of diabetes or glycemic control of the patient; however, several biochemical factors also alter the process. Our aim was to investigate the role of soluble E-selectin in...
